以岭药业：2025年第三季度归属于上市公司股东的净利润同比增长1264.61%

Core Insights - Yiling Pharmaceutical reported a revenue of 1,827,460,855.67 yuan for Q3 2025, representing a year-on-year growth of 3.78% [2] - The net profit attributable to shareholders of the listed company reached 331,869,647.18 yuan, showing a significant year-on-year increase of 1264.61% [2] Financial Performance - The company's revenue for Q3 2025 was approximately 1.83 billion yuan, reflecting a modest growth compared to the previous year [2] - The net profit for the same period was around 331.87 million yuan, indicating an extraordinary increase in profitability [2]